Chinese Regulator Approves MicroPort Scientific's Firesorb Stent for Marketing

MT Newswires Live2024-07-31

MicroPort Scientific's (HKG:0853) self-developed Firesorb Bioresorbable Scaffold System was approved for marketing by the National Medical Products Administration of China on Tuesday, July 30, a same-day filing with the Hong Kong Exchange said.

Firesorb Bioresorbable Scaffold System or the Firesorb Stent is developed for the treatment of coronary artery-related diseases. The stent has proven to be non-inferior to permanent drug-eluting stents in the market.

It is the first target eluting bioresorbable stent with the same thickness as a metal stent and the same support level. Its target eluting technology reduces the effective drug load to one-third of the load used in the world while keeping the same efficacy. It can also be used in the treatment of small-vessel lesion areas up to 2.5 millimeters in diameter.

Clinical studies showed that the rate of clotting with the Firesorb stent is relatively low and is comparable to other permanent drug-eluting stents in the market while the numbers showed that the stent was better than other biodegradable stents in the market.

The company's shares were up 8% on Wednesday's close.

Price (HKD): $5.35, Change: $+0.40, Percent Change: +8.08%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2455182327?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-07-31 19:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2455182327","market":"fut","top_or_hot":-1,"title":"Chinese Regulator Approves MicroPort Scientific's Firesorb Stent for Marketing","media":"MT Newswires Live","content":"<html><body><p> MicroPort Scientific's (HKG:0853) self-developed Firesorb Bioresorbable Scaffold System was approved for marketing by the National Medical Products Administration of China on Tuesday, July 30, a same-day filing with the Hong Kong Exchange said.</p><p>Firesorb Bioresorbable Scaffold System or the Firesorb Stent is developed for the treatment of coronary artery-related diseases. The stent has proven to be non-inferior to permanent drug-eluting stents in the market.</p><p>It is the first target eluting bioresorbable stent with the same thickness as a metal stent and the same support level. Its target eluting technology reduces the effective drug load to one-third of the load used in the world while keeping the same efficacy. It can also be used in the treatment of small-vessel lesion areas up to 2.5 millimeters in diameter.</p><p>Clinical studies showed that the rate of clotting with the Firesorb stent is relatively low and is comparable to other permanent drug-eluting stents in the market while the numbers showed that the stent was better than other biodegradable stents in the market.</p><p>The company's shares were up 8% on Wednesday's close.</p><p>Price (HKD): $5.35, Change: $+0.40, Percent Change: +8.08%</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chinese Regulator Approves MicroPort Scientific's Firesorb Stent for Marketing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChinese Regulator Approves MicroPort Scientific's Firesorb Stent for Marketing\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-07-31 19:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>MicroPort Scientific's (HKG:0853) self-developed Firesorb Bioresorbable Scaffold System was approved for marketing by the National Medical Products Administration of China on Tuesday, July 30, a same-...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2455182327","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2455182327","pubTimestamp":1722426288,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"MicroPort Scientific's  self-developed Firesorb Bioresorbable Scaffold System was approved for marketing by the National Medical Products Administration of China on Tuesday, July 30, a same-day filing with the Hong Kong Exchange said.Firesorb Bioresorbable Scaffold System or the Firesorb Stent is developed for the treatment of coronary artery-related diseases. The stent has proven to be non-inferior to permanent drug-eluting stents in the market.It is the first target eluting bioresorbable stent with the same thickness as a metal stent and the same support level. Its target eluting technology reduces the effective drug load to one-third of the load used in the world while keeping the same efficacy. It can also be used in the treatment of small-vessel lesion areas up to 2.5 millimeters in diameter.Clinical studies showed that the rate of clotting with the Firesorb stent is relatively low and is comparable to other permanent drug-eluting stents in the market while the numbers showed that","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"中国监管机构批准微创科技Firesorb支架上市","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HKD":1,"00853":0.9},"content_text":"MicroPort Scientific's (HKG:0853) self-developed Firesorb Bioresorbable Scaffold System was approved for marketing by the National Medical Products Administration of China on Tuesday, July 30, a same-day filing with the Hong Kong Exchange said.Firesorb Bioresorbable Scaffold System or the Firesorb Stent is developed for the treatment of coronary artery-related diseases. The stent has proven to be non-inferior to permanent drug-eluting stents in the market.It is the first target eluting bioresorbable stent with the same thickness as a metal stent and the same support level. Its target eluting technology reduces the effective drug load to one-third of the load used in the world while keeping the same efficacy. It can also be used in the treatment of small-vessel lesion areas up to 2.5 millimeters in diameter.Clinical studies showed that the rate of clotting with the Firesorb stent is relatively low and is comparable to other permanent drug-eluting stents in the market while the numbers showed that the stent was better than other biodegradable stents in the market.The company's shares were up 8% on Wednesday's close.Price (HKD): $5.35, Change: $+0.40, Percent Change: +8.08%","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.2","shortVersion":"4.30.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2455182327"}